hotspot -WSS

hotspot

author：focus 2025-09-03 09:25:48 - browse：679

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Asahi Kasei to buy Calliditas, picking up kidney disease drug

WSS

Congress: Prevent baby formula shortages by passing a new bill

Lawsuit challenges CMS nursing home minimum staffing rule

Decentralized clinical trials need collaboration to achieve wider use

Chimpanzees, like humans and whales, get menopause: Study

Testing for cancer recurrence creates a new limbo for patients

Maker of FluMist seeks to allow at

Wikipedia

hotspot

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Stroke rates rising, especially in working

Peter Hotez and the public health issue of online harassment

U.S. death rates show how politics are affecting public health

In age of alternative facts, a scholarly course on calling out crap

Unmasking the 'centricity' illusion in clinical trials

Sports medicine is finally prioritizing gender equality

Stroke rates rising, especially in working

Guidelines to prevent youth baseball injuries need more muscle

First Opinion Podcast: How to protect health care in times of war

hotspot

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Biden's order seeks to regulate AI risk without stifling innovation

Beyond aggravation: Constipation is an American epidemic

Pharma’s losing bet in New Jersey

WHO may add ‘noma' to its list of neglected tropical diseases

Guardant Health colon cancer test endorsed by FDA advisory panel

Wikipedia

hotspot

entertainment

focus